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Abstract 
Egg yolk phosvitin is one of the most phosphorylated 
proteins in nature, and thus has a strong metal-binding 
ability. The objective of this study was to evaluate the 
cytotoxic and antigenotoxic activities of phosvitin in vitro. 
Using the MTT assay, the cytotoxicity of phosvitin was 
evaluated in human cancer cell lines of various tissue 
origins, including the cervix (HeLa), breast (MCF-7), 
stomach (AGS), lung (A549 and SK-MES-1), liver (HepG2), 
and larynx (Hep-2). The growth of all cancer cell lines was 
inhibited in a dose-dependent manner by phosvitin. Among 
the cancer cell lines tested, MCF-7 and SK-MES-1 were the 
least sensitive and HeLa, AGS, and HepG2 were the most 
sensitive to phosvitin. The IC50 values of phosvitin were 
5.38, 11.57, 4.78, 6.98, 11.82, 3.93, and 9.97 mg/mL for 
HeLa, MCF-7, AGS, A549, SK-MES-1, HepG2, and Hep-2, 
respectively. The protective effects of phosvitin against 
DNA damage in human leukocytes indicated that phosvitin 
showed protective effects against the oxidative stress-
induced DNA damages in human leukocytes. These results 
suggested that phosvitin has a high potential to be used as 
an anticancer agent for humans.  
 
Introduction 
DNA damage and oxidative stress play important roles 
in various illnesses and pathological conditions, including 
carcinogenesis and aging, in human. Cancer is the second 
leading cause of mortality worldwide, and scientific society 
and commercial sectors show very strong interests in 
discovering new anticancer agents from natural sources. In 
recent years, some scientific evidences indicated that certain 
bioactive proteins and peptides could have several beneficial 
effects on human health.  
Phosvitin is a phosphoglycoprotein present in egg yolk 
and represents about 7% of yolk proteins. The molecular 
weight of phosvitin ranges from 35 to 40 kDa and is 
composed of 217 amino acids residues. More than 50% of 
the amino acid residues in phosvitin are serine and 90% of 
which are phosphorylated. This specific structure makes 
phosvitin a very strong metal (iron, calcium, magnesium, 
etc.) chelator.  
Phosvitin is reported to have metal-chelating, 
antioxidant, emulsifying, and antimicrobial activities. It was 
found that phosvitin has a high iron-binding capacity, 
exhibited a strong antibacterial activity against a broad 
spectrum of bacteria, and has anti-tyrosinase and melanin 
biosynthesis activities. However, there has been little study 
on the anticancer activity of phosvitin from egg yolk, so far. 
The objective of this study was to investigate the 
antigenotoxic activity of phosvitin against normal human 
peripheral blood mononuclear cells (PBMCs) and cytotoxic 
activity of phosvitin against human cancer cell lines. 
 
Materials and Methods 
Phosvitin was prepared from chicken egg yolk.  
Human normal and cancer cell lines including HeLa and 
HepG2, MCF-7 (human breast adenocarcinoma), AGS, and 
A549 cell lines were used to evaluate the cytotoxic and 
antigenotoxic activities of phosvitin in vitro. The cytotoxic 
effect of phosvtin was tested in vitro using the 3-(4,5-
dimethylthizol-2-yl)-2,5-diphenylatetetrazolium bromide 
(MTT) assay. The concentration required for a 50% 
inhibition of cell viability (IC50) was determined graphically. 
DNA Damage was determined by Alkaline Comet Assay.  
 
Statistical Analysis: All cytotoxicity of phosvitin results 
were presented as mean ± standard error (SE), and statistical 
analysis was performed using the SPSS package for 
Windows. The IC50 value was calculated by Soft Max Pro 
version 6.3. The mean values were compared using the one-
way analysis of variance (ANOVA) followed by Duncan’s 
multiple range tests (p < 0.05).  
 
Results and Discussion 
In vitro Cytotoxicity of Phosvitin: Different cells had a 
different sensitivity to the growth inhibition effect of 
phosvitin (Fig. 1). The results expressed as IC50 represent 
the effective concentration of phosvitin required for 50% 
cytotoxic activity under the experimental conditions (Table 
1). In the present study, the cytotoxic effect of phosvitin on 
normal cells (MRC-5) was significantly different from that 
on human cancer cells. At all concentrations of phosvitin, 
there was no more than 20% of cytotoxic activity against 
MRC-5 cells. 
Phosvitin showed a strong cytotoxic effect and the 
effect increased as the level of phosvitin increased. 
Phosvitin at 40 mg/mL displayed 94.63% cytotoxicity to 
HeLa cells (Fig. 1A) and the IC50 value of phosvitin to 
HeLa cells was 5.38 mg/mL (Table 1). Phosvitin showed a 
weak cytotoxic activity to MCF-7 cells at low concentration 
(10 mg/mL), but it suppressed the growth of MCF-7 cells in 
a dose-dependent manner (Fig. 1B). Phosvitin inhibited the 
growth of AGS cells by 40.84, 55.30, 62.03, 88.23, and 
93.67% at concentrations at 2.5, 5, 10, 20, and 40 mg/mL, 
respectively. The IC50 value of phosvitin to AGS cells was 
Iowa State University Animal Industry Report 2016 
 
4.78 mg/mL (Fig. 1C) and that of A549 cells was 6.98 
mg/mL (Fig. 1D). The SK-MES-1 cells were the least 
sensitive to phosvitin among the cancer cell lines tested. The 
IC50 value of phosvitin to SK-MES-1 cells was 11.825 
mg/mL (Table 1), but increasing the concentration of 
phosvitin from 2.5 to 5 mg/mL resulted in no growth 
inhibition, as assessed by the MTT assay (Fig. 1E). 
Phosvitin showed IC50 value of 3.93 mg/mL to HepG2 cells 
and > 70% cytotoxicity was observed at 10 mg/mL level. 
The effect of phosvitin to HepG2 cells was more 
pronounced than other cancer cells tested (p < 0.05). The 
IC50 value of phosvitin to Hep-2 cells was 9.97 mg/mL (Fig. 
1G), which is more resistant to phosvitin than HeLa, AGS, 
A549, and HepG2 cells. No significant decrease in cell 
viability at 5-500 μg/mL level was observed.  
 
Inhibitory Effects on H2O2-Induced DNA Damage: The 
comet assay has been used as one of the standard methods 
for assessing direct and indirect damages to DNA. Reactive 
oxygen species such as hydrogen peroxide, superoxide 
anion, singlet oxygen, and hydroxyl radical are well known 
stress agents for DNA damages. When oxidative stress 
continuously occurs, it causes DNA damage in cells and 
raises the risk of diseases such as aging or cancer.  
The genetoxic effects of H2O2 and the protective ability 
of phosvitin was assessed in normal human leukocytes using 
the comet assay (Fig. 2). The protective effect of phosvitin 
against DNA damages increased in a dose-dependent 
manner over the range of 50-500 μg/mL. When phosvitin 
was added at the concentrations of 50-500 μg/mL, the tail 
portion (%) of DNA (damaged portion) was 23.62%-15.48% 
while that of the positive control was 35.04%, which was 
significant reduction from the positive control. At a higher 
level of phosvitin (500 μg/mL), the damaged DNA was 
reduced by 55.8%. The concentrations of phosvitin that 
produced 50% reduction in DNA damage was 424.59 
μg/mL.  
The results of this study indicated that phosvitin has 
antigenotoxicity and cytotoxic activity against several 
human cancer cell lines and has some potential to be used as 
an anticancer agent for humans. 
 
 
Table 1. The phosvitin concentrations that inhibit 50% of the cell growth (IC50) on various human cancer cell lines 
Cancer cells 
IC50 (mg/mL)1 
HeLa MCF-7 AGS A549 SK-MES-1 HepG2 Hep-2 
Phosvitin 5.38±2.25 11.57±1.19 4.78±1.71 6.98±1.82 11.82±1.21 3.93±0.96 9.97±0.18 
Values are mean ± standard error (n = 3). 
1IC50 value means the effective concentration of phosvitin required for 50% cytotoxic activity under the experimental 
condition. 
Abbreviations: HeLa, human cervix adenocarcinoma; MCF-7, human breast adenocarcinoma; AGS, human stomach 
adenocarcinoma; A549, human lung adenocarcinoma; SK-MES-1, human lung carcinoma; HepG2, human liver 
hepatoblastoma; Hep-2, human larynx carcinoma. 
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Figure 1. The cytotoxic effects1 of phosvitin on various human cancer cell lines by MTT assay. (A) HeLa cell, (B) MCF-7 
cell, (C) AGS cell, (D) A549 cell, (E) SK-MES-1 cell, (F) HepG2 cell, and (G) Hep2 cell. Values are means with standard 
errors. Values not sharing the same letter are significantly different (p < 0.05) (n = 3).   
1Cytotoxic effect (%) = 1-(absorbance in the samples/absorbance in the control) × 100. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Effect of phosvitin on 200 μM H2O2-induced DNA damage by comet assay. Values are means with standard errors. 
Values not sharing the same letter are significantly different (P < 0.05) (n=3).  
Abbreviations: NC, negative control (without oxidative stimulus); PC, 200 μM H2O2-treated positive control.   
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